
Description
Documents
Product Manuals
No Documents AvailableImages
No Images AvailableProduct Information
Product Size | 5 mg |
Form | Solid |
Absorption (estimated) | Wavelength (λmax) 234 ± 3 nm |
Fluorescence (estimated) | Excitation / Emission maxima about 496 ± 3 nm / 520 ± 4 nm nm after enzymatic hydrolysis |
Cell Permeability | Cell-permeant |
Detection Method | Fluorescent enzymatic product |
Storage conditions | Freeze: Store at -5 to -30°C (F) Protect from moisture (D) Protect from light (L) |
Shipping conditions | Room temperature |
Storage Condition |
||
Store -5 to -30oC (F) |
Protect from Moisture (D) |
Protect from Light (L) |
• Butanoic acid, 4,4'-[(3-oxospiro[isobenzofuran-1(3H0,9'-[9H]xanthene]-3'6'-diyl)diimino]bis[3-amino-4-oxo-, (3S,3'S)-, bis(trifluoroacetate)
• D2R
- Rh110-2(Asp) Caspase Substrate
• Mukhopadhyay P, Rajesh M, Bátkai S, Kashiwaya Y, Haskó G, Liaudet L, Szabó C, Pacher P, Am J Physiol Heart Circ Physiol (2009) 296:H1466-H1483
• Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR, Greenamyre JT. J Neurosci 22, 7006-15 (2002)
• Biochem. 38, 13906 (1999)
For Research Use Only. Not for any animal or human therapeutic or diagnostic use No Animal source |
|||||||
Regulatory Compliance |
|||||||
6278 |
Rh110-2(Asp) [Rhodamine 110, bis-(L-aspartic acid amide), trifluoroacetic acid salt] |
||||||
OSHA Hazard |
No Known OSHA Hazards |
||||||
HMIS Classification |
Health: 0 |
Flammability: 0 |
Physical Hazard: 0 |
||||
NFPA Rating |
Health: 0 |
Fire: 0 |
Reactivity: 0 |
||||
TSCA Status |
Not On TSCA Inventory |
||||||
Transportation Information |
|||||||
DOT (US) |
IMDG |
IATA |
|||||
Not dangerous goods |
Not dangerous goods |
Not dangerous goods |